Study design and treatment
The NEXUS trial is a multicenter phase II clinical study that will evaluate the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab (the BEACON triplet regimen) in patients with previously untreated but surgically resectable Eligibility criteria of the NEXUS study